BMED vs. ARKG

Last updated Jun 23, 2026

BMED (Future Health ETF) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both Health & Biotech Equities funds. Both are actively managed. Over the past 5 years, BMED returned -1.08%/yr vs -16.18%/yr for ARKG. A 0.78 correlation means they provide meaningful diversification when combined. BMED charges 0.85%/yr vs 0.75%/yr for ARKG.

Performance

BMED vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Future Health ETF (BMED) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BMED achieves a -5.53% return, which is significantly lower than ARKG's 25.65% return.

BMED

• 1D: 0.50%
• 1M: 2.01%
• YTD: -5.53%
• 6M: -6.79%
• 1Y: 18.30%
• 3Y*: 5.25%
• 5Y*: -1.08%
• 10Y*: —

ARKG

• 1D: -1.25%
• 1M: 18.68%
• YTD: 25.65%
• 6M: 18.88%
• 1Y: 52.94%
• 3Y*: 3.54%
• 5Y*: -16.18%
• 10Y*: 8.79%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BMED vs. ARKG - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
BMED Future Health ETF	-5.53%	21.79%	1.55%	5.70%	-19.69%	-3.96%	17.62%
ARKG ARK Genomic Revolution Multi-Sector ETF	25.65%	23.04%	-28.24%	16.22%	-53.90%	-33.92%	47.53%

Correlation

The correlation between BMED and ARKG is 0.69, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.69
Correlation (3Y) Calculated over the trailing 3-year period	0.74
Correlation (5Y) Calculated over the trailing 5-year period	0.77
Correlation (All Time) Calculated using the full available price history since Oct 1, 2020	0.78

The correlation between BMED and ARKG has been stable across timeframes, ranging from 0.69 to 0.78 - a consistent structural relationship.

BMED vs. ARKG - Sectors Allocation Comparison

Sectors	BMED	ARKG
Healthcare	100.0%	99.3%
Consumer Defensive	1.5%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Energy	-	-
Financial Services	-	0.5%
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

BMED vs. ARKG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BMED

BMED Risk / Return Rank: 30
BMED Sharpe Ratio Rank: 35
BMED Sortino Ratio Rank: 35
BMED Omega Ratio Rank: 31
BMED Calmar Ratio Rank: 26
BMED Martin Ratio Rank: 23

ARKG

ARKG Risk / Return Rank: 36
ARKG Sharpe Ratio Rank: 36
ARKG Sortino Ratio Rank: 38
ARKG Omega Ratio Rank: 33
ARKG Calmar Ratio Rank: 40
ARKG Martin Ratio Rank: 33

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BMED vs. ARKG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Future Health ETF (BMED) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BMED	ARKG	Difference
Sharpe ratio: Return per unit of total volatility	1.20	1.25	-0.06
Sortino ratio: Return per unit of downside risk	1.78	1.92	-0.14
Omega ratio: Gain probability vs. loss probability	1.21	1.22	-0.01
Calmar ratio: Return relative to maximum drawdown	1.24	1.93	-0.70
Martin ratio: Return relative to average drawdown	2.91	4.60	-1.70

BMED vs. ARKG - Sharpe Ratio Comparison

The current BMED Sharpe Ratio is 1.20, which is comparable to the ARKG Sharpe Ratio of 1.25. The chart below compares the historical Sharpe Ratios of BMED and ARKG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BMED vs. ARKG - Drawdown Comparison

The maximum BMED drawdown since its inception was -36.44%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for BMED and ARKG.

Drawdown Indicators

	BMED	ARKG	Difference
Max Drawdown Largest peak-to-trough decline	-36.44%	-83.59%	+47.15%
Max Drawdown (1Y) Largest decline over 1 year	-14.85%	-27.51%	+12.66%
Max Drawdown (3Y) Largest decline over 3 years	-20.12%	-51.96%	+31.84%
Max Drawdown (5Y) Largest decline over 5 years	-33.90%	-80.18%	+46.28%
Max Drawdown (10Y) Largest decline over 10 years	—	-83.59%	—
Current Drawdown Current decline from peak	-11.49%	-67.43%	+55.94%
Average Drawdown Average peak-to-trough decline	-19.02%	-36.00%	+16.98%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.31%	11.53%	-5.22%

Volatility

BMED vs. ARKG - Volatility Comparison

The current volatility for Future Health ETF (BMED) is 4.74%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 15.26%. This indicates that BMED experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BMED	ARKG	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.74%	15.26%	-10.52%
Volatility (6M) Calculated over the trailing 6-month period	11.37%	30.89%	-19.52%
Volatility (1Y) Calculated over the trailing 1-year period	15.41%	42.61%	-27.20%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.45%	45.93%	-28.48%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.74%	41.30%	-23.56%

BMED vs. ARKG - Expense Ratio Comparison

BMED has a 0.85% expense ratio, which is higher than ARKG's 0.75% expense ratio.

Dividends

BMED vs. ARKG - Dividend Comparison

BMED's dividend yield for the trailing twelve months is around 0.28%, while ARKG has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
ARKG ARK Genomic Revolution Multi-Sector ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.62%	0.85%	3.14%	0.82%	1.34%
BMED Future Health ETF	0.28%	0.00%	0.00%	0.03%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both BMED and ARKG in my portfolio?

BMED and ARKG have a correlation of 0.69, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BMED or ARKG?

ARKG has higher volatility (15.26%) compared to BMED (4.74%). In terms of maximum drawdown, BMED dropped -36.44% vs ARKG's -83.59%.

Which ETF is better, BMED or ARKG?

On 5-year performance, BMED leads with -1.08% vs -16.18% for ARKG. On fees, ARKG is cheaper at 0.75% per year. On volatility, BMED has been the lower-risk option at 4.74%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, BMED or ARKG?

Over the 5-year period, BMED has performed better with a -1.08% return vs -16.18%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, BMED or ARKG?

ARKG is cheaper with a 0.75% expense ratio, compared with 0.85% for BMED.

Which ETF pays a higher dividend yield, BMED or ARKG?

BMED has the higher dividend yield at 0.28%, compared with 0.00% for ARKG.

What is the main difference between BMED and ARKG?

They also come from different issuers: BlackRock and ARK. Their fees differ too: 0.85% for BMED and 0.75% for ARKG.

Which has better risk-adjusted returns?

ARKG currently has the higher Sharpe Ratio (1.25 vs 1.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.